Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 812 participants.
Also called NCT01415505
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 812 participants
- Sponsor
- Registry
-
NCT01415505
-
- Other papers using this trial's data
- Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01415505. Randomized; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Nebivolol, Valsartan and Hydrochlorothiazide
- Lead sponsor
- Forest Laboratories
Record details
- Record id
cardio:ct-nct01415505- Content hash
0c545a9b3eb3cc42bcbf64ecbc488f8e867798bd9c6ed1dc127a7ffd7fc8dc07